The ‘eternal’ dilemma of OPCABG versus ONCABG continues: superior, equal, inferior or just different?

aCardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre

bCardiovascular Research Institute Maastricht, Maastricht, Netherlands

cDepartment of Cardiac Surgery, University of Szeged, Szeged, Hungary

Correspondence to Roberto Lorusso, Prof. Dr, MD, PhD, FELSO, FEACTS, FHFA, Deputy Director, Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6202 AZ Maastricht, Netherlands Tel: +31 43 3876032; e-mail: [email protected]; [email protected]

Received 14 April, 2022

Accepted 29 May, 2022

留言 (0)

沒有登入
gif